Our final demethylation target was the FMR1 gene which, in patients with Fragile X syndrome, undergoes a CGG repeat expansion (>200 repeats) in its 5′ UTR that becomes aberrantly hypermethylated and results in silencing of FMR1 transcription77. The gene discussed is FMR1; the disease is fragile X syndrome.